ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Boston, MA, USA:

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not rec...

Enrolling
Indolent Non-hodgkin Lymphoma
Marginal Zone Lymphoma
Drug: Obinutuzumab
Drug: Glofitamab

Phase 2

Reid Merryman, MD

Boston, Massachusetts, United States and 1 other location

In this research study is looking to see how safe and effective belantamab mafodotin is in relapsed or refractory plasmablastic lymphoma or ...

Enrolling
Refractory Plasmablastic Lymphoma
Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma
Drug: Belantamab Mafodotin

Phase 2

Jacob Soumerai, MD

Boston, Massachusetts, United States and 2 other locations

of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma...

Enrolling
Low Grade Non-Hodgkin's Lymphoma, Adult
Follicular Lymphoma
Drug: Rituximab
Drug: Epcoritamab

Phase 2

Reid Merryman, MD

Boston, Massachusetts, United States and 2 other locations

therapy in treating relapsed/refractory central nervous system (CNS) lymphoma, systemic lymphoma with concurrent CNS lymphoma...

Active, not recruiting
Lymphoma Cns
Lymphoma
Drug: Cyclophosphamide
Biological: Axicabtagene Ciloleucel

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 1 other location

This research study is studying several new investigational drug combinations as a possible treatment for follicular lymphoma.The drugs invo...

Active, not recruiting
Follicular Lymphoma
Drug: Avelumab
Drug: PF04518600

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 5 other locations

In this study, is researching the safety of tisagenlecleucel in participants with primary central nervous system lymphoma. .-The name of the...

Active, not recruiting
Primary CNS Lymphoma
Relapsed Primary CNS Lymphoma
Biological: Tisagenlecleucel

Phase 1

Matthew J. Frigault, M.D.

Boston, Massachusetts, United States

This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This study will consist of...

Active, not recruiting
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Drug: imvotamab

Phase 1, Phase 2

IGM Biosciences

Boston, Massachusetts, United States and 26 other locations

back) or refractory (cancer has not responded to treatment) B-cell Lymphoma and will be undergoing CAR T-cell Therapy.This research is being...

Enrolling
Refractory Lymphoma
Lymphoma, B-Cell
Radiation: Adaptive Bridging Radiation Therapy (ABRT)
Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 1 other location

Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly among people from the Caribbean islands, Western Africa, Brazil,...

Active, not recruiting
Lymphoma
Adult T-Cell Leukemia/Lymphoma
Drug: CHEP
Drug: Brentuximab Vedotin

Phase 2

UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center

Boston, Massachusetts, United States and 3 other locations

DS-3201b is an experimental drug. It is not approved for regular use. It can only be used in clinical research.Adults with non-Hodgkin lymphoma...

Active, not recruiting
Lymphoma, Malignant
Non-hodgkin Lymphoma
Drug: DS-3201b

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Boston, Massachusetts, United States and 20 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems